APIC for Older Adults
(APIC Trial)
What You Need to Know Before You Apply
What is the purpose of this trial?
This trial tests a program called Personalised Citizen Assistance for Social Participation (APIC), which aims to help older adults stay healthy and engaged in their communities. Participants will attend weekly sessions with a trained volunteer for a year to boost their involvement and connections with others. The goal is to determine if this program improves health, life satisfaction, and reduces healthcare use and costs. This trial may suit those aged 65 and older who live at home or in senior residences, struggle with tasks like shopping or cleaning, and understand French or English. As an unphased trial, this study offers a unique opportunity to contribute to research that could enhance community engagement and well-being for older adults.
Will I have to stop taking my current medications?
The trial information does not specify whether you need to stop taking your current medications.
What prior data suggests that the APIC intervention is safe for older adults?
Research has shown that Personalized Citizen Assistance for Social Participation (APIC) is a promising method for helping older adults. Studies have found that APIC increases social activities, movement, and leisure time for older adults. It also improves their mental and physical health, sense of connection, and motivation.
Regarding safety, studies involving APIC have reported no negative effects, suggesting it is well-tolerated. The sessions aim to empower individuals and help them connect with their community, making it a supportive and safe option. For those considering joining a trial with APIC, current data suggests it is a safe choice.12345Why are researchers excited about this trial?
Researchers are excited about the APIC (Personalised citizen assistance for social participation) because it approaches the well-being of older adults in a unique way. Unlike traditional care, which often focuses on medical or physical interventions, APIC emphasizes social engagement and empowerment through personalized weekly sessions. These sessions are designed to mobilize personal and environmental resources and integrate participants into their communities, potentially improving mental and social health. This approach could offer a more holistic method of enhancing quality of life for older adults beyond standard healthcare services.
What evidence suggests that the APIC intervention is effective for improving older adults' health and social participation?
Research has shown that the Personalised Citizen Assistance for Social Participation (APIC), which participants in this trial may receive, positively affects the lives of older adults. Studies have found that APIC helps older adults become more independent, enabling them to do more on their own. Participants reported feeling happier with their social interactions. Some evidence suggests that APIC assists older adults with vision problems in overcoming social challenges. Overall, APIC appears to increase community involvement and improve the quality of life for older adults.46789
Who Is on the Research Team?
Mélanie Levasseur
Principal Investigator
Université de Sherbrooke; Research centre on aging
Are You a Good Fit for This Trial?
This trial is for older adults aged 65 or above who live at home or in senior residences, have difficulty with daily tasks like house cleaning or shopping, and understand French or English well. It's not suitable for those with moderate to severe cognitive impairments.Inclusion Criteria
Exclusion Criteria
Timeline for a Trial Participant
Screening
Participants are screened for eligibility to participate in the trial
Treatment
Participants receive weekly 3-hour personalised stimulation sessions by a trained volunteer over 12 months
Follow-up
Participants are monitored for health, social participation, and life satisfaction outcomes
What Are the Treatments Tested in This Trial?
Interventions
- Personalised citizen assistance for social participation(APIC)
Find a Clinic Near You
Who Is Running the Clinical Trial?
Mélanie Levasseur
Lead Sponsor
Canadian Institutes of Health Research (CIHR)
Collaborator